0013SP |
Acamprosate, Serum/Plasma |
0088B |
Acetonitrile Exposure Profile, Blood |
0148B |
Acrylonitrile Exposure Profile, Blood |
0275SP |
Dalfampridine, Serum/Plasma |
0275U |
Dalfampridine, Urine |
0307B |
Amiodarone and Metabolite, Blood |
0307SP |
Amiodarone and Metabolite, Serum/Plasma |
0329B |
Amphetamines (D/L Differentiation), Blood |
0329FL |
Amphetamines (D/L Differentiation), Fluid |
0329SP |
Amphetamines (D/L Differentiation), Serum/Plasma |
0329U |
Amphetamines (D/L Differentiation), Urine |
0406B |
Anticoagulant Poisoning Panel (Qualitative), Blood |
0406SP |
Anticoagulant Poisoning Panel (Qualitative), Serum/Plasma |
0406TI |
Anticoagulant Poisoning Panel (Qualitative), Tissue |
0451B |
Aripiprazole, Blood |
0451SP |
Aripiprazole, Serum/Plasma |
0474SP |
Asenapine, Serum/Plasma |
0620B |
Benztropine, Blood |
0620SP |
Benztropine, Serum/Plasma |
0620TI |
Benztropine, Tissue |
0620U |
Benztropine, Urine |
0641B |
Sotalol, Blood |
0641SP |
Sotalol, Serum/Plasma |
0649SP |
Methotrexate, Serum/Plasma |
0716SP |
Brexpiprazole, Serum/Plasma |
0718B |
Brivaracetam, Blood |
0718SP |
Brivaracetam, Serum/Plasma |
0796B |
Bumetanide, Blood |
0796SP |
Bumetanide, Serum/Plasma |
0800B |
Bupivacaine, Blood |
0800FL |
Bupivacaine, Fluid |
0800SP |
Bupivacaine, Serum/Plasma |
0800U |
Bupivacaine, Urine |
0803B |
Bupropion and Metabolite, Blood |
0803FL |
Bupropion and Metabolite, Fluid |
0803SP |
Bupropion and Metabolite, Serum/Plasma |
0803TI |
Bupropion and Metabolite, Tissue |
0803U |
Bupropion and Metabolite, Urine |
0805B |
Buspirone, Blood |
0805SP |
Buspirone, Serum/Plasma |
0805U |
Buspirone, Urine |
0970B |
Carbamazepine and Metabolite, Blood |
0970FL |
Carbamazepine and Metabolite, Fluid |
0970SP |
Carbamazepine and Metabolite, Serum/Plasma |
0970TI |
Carbamazepine and Metabolite, Tissue |
0971SP |
Carbamazepine and Metabolite - Free, Serum/Plasma |
0972SP |
Carbamazepine and Metabolite - Total/Free/Bound, Serum/Plasma |
0975SP |
Carbamazepine-10,11-Epoxide, Serum/Plasma |
0975U |
Carbamazepine-10,11-Epoxide, Urine |
0985B |
Carbinoxamine, Blood |
0995U |
Carbon Disulfide Exposure (TTCA), Urine |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1056B |
Cenobamate, Blood |
1056SP |
Cenobamate, Serum/Plasma |
1180B |
Chlorothiazide, Blood |
1180SP |
Chlorothiazide, Serum/Plasma |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1255B |
Chlorzoxazone, Blood |
1255SP |
Chlorzoxazone, Serum/Plasma |
1287B |
Clozapine and Metabolite, Blood |
1287FL |
Clozapine and Metabolite, Fluid |
1287SP |
Clozapine and Metabolite, Serum/Plasma |
1287TI |
Clozapine and Metabolite, Tissue |
1287U |
Clozapine and Metabolite, Urine |
1320B |
Colchicine, Blood |
1320SP |
Colchicine, Serum/Plasma |
1320TI |
Colchicine, Tissue |
1355U |
o-Toluidine, Urine |
1380B |
Cyanide, Blood |
1405B |
Cyclobenzaprine, Blood |
1405FL |
Cyclobenzaprine, Fluid |
1405SP |
Cyclobenzaprine, Serum/Plasma |
1405TI |
Cyclobenzaprine, Tissue |
1405U |
Cyclobenzaprine, Urine |
1415B |
Cyclosporine, Blood |
1425B |
Cyproheptadine, Blood |
1425SP |
Cyproheptadine, Serum/Plasma |
1425U |
Cyproheptadine, Urine |
1575B |
Dicyclomine, Blood |
1575SP |
Dicyclomine, Serum/Plasma |
1575U |
Dicyclomine, Urine |
1615B |
Digoxin, Blood |
1615FL |
Digoxin, Fluid |
1615SP |
Digoxin, Serum/Plasma |
1615TI |
Digoxin, Tissue |
1760B |
Diphenhydramine, Blood |
1760FL |
Diphenhydramine, Fluid |
1760SP |
Diphenhydramine, Serum/Plasma |
1760TI |
Diphenhydramine, Tissue |
1760U |
Diphenhydramine, Urine |
1804SP |
Diuretics Panel, Serum/Plasma |
1812B |
Donepezil, Blood |
1812FL |
Donepezil, Fluid |
1812SP |
Donepezil, Serum/Plasma |
1828B |
Dronedarone, Blood |
1828SP |
Dronedarone, Serum/Plasma |
1900B |
Dyazide, Blood |
1900SP |
Dyazide, Serum/Plasma |
1968B |
Eszopiclone / Zopiclone, Blood |
1968SP |
Eszopiclone / Zopiclone, Serum/Plasma |
1968TI |
Eszopiclone / Zopiclone, Tissue |
1968U |
Eszopiclone / Zopiclone, Urine |
2029U |
Ethylbenzene Exposure Biouptake, Urine |
2066B |
Everolimus, Blood |
2069B |
Felbamate, Blood |
2069SP |
Felbamate, Serum/Plasma |
2110B |
Fluphenazine, Blood |
2111B |
Baclofen, Blood |
2111FL |
Baclofen, Fluid |
2111SP |
Baclofen, Serum/Plasma |
2111U |
Baclofen, Urine |
2115SP |
Fluphenazine, Serum/Plasma |
2136B |
Fosphenytoin as Metabolite, Blood |
2136SP |
Fosphenytoin as Metabolite, Serum/Plasma |
2148B |
Galantamine, Blood |
2148SP |
Galantamine, Serum/Plasma |
2185B |
Guaifenesin, Blood |
2185SP |
Guaifenesin, Serum/Plasma |
2185U |
Guaifenesin, Urine |
2187SP |
Ganaxolone, Serum/Plasma |
2220B |
Haloperidol, Blood |
2220SP |
Haloperidol, Serum/Plasma |
2220TI |
Haloperidol, Tissue |
2358U |
1-Hydroxypyrene, Urine |
2365B |
Hydroxyzine and Metabolite, Blood |
2365FL |
Hydroxyzine and Metabolite, Fluid |
2365SP |
Hydroxyzine and Metabolite, Serum/Plasma |
2365U |
Hydroxyzine and Metabolite, Urine |
2369B |
Hyoscyamine, Blood |
2369SP |
Hyoscyamine, Serum/Plasma |
2369U |
Hyoscyamine, Urine |
2395B |
Iloperidone, Blood |
2395SP |
Iloperidone, Serum/Plasma |
2397SP |
Indapamide, Serum/Plasma |
2416U |
Aromatic Solvents Metabolites Panel, Urine |
2425B |
Ipecac Use Markers Screen, Blood |
2425FL |
Ipecac Use Markers Screen, Fluid |
2425SP |
Ipecac Use Markers Screen, Serum/Plasma |
2425U |
Ipecac Use Markers Screen, Urine |
2456SP |
Isotretinoin, Serum/Plasma |
2458SP |
Isotretinoin and Metabolite, Serum/Plasma |
2479B |
Ketamine and Metabolite, Blood |
2479FL |
Ketamine and Metabolite, Fluid |
2479SP |
Ketamine and Metabolite, Serum/Plasma |
2479TI |
Ketamine and Metabolite, Tissue |
2479U |
Ketamine and Metabolite, Urine |
2484B |
Lamotrigine, Blood |
2484SP |
Lamotrigine, Serum/Plasma |
2484U |
Lamotrigine, Urine |
2499U |
Laxatives Panel (Qualitative), Urine |
2505B |
Levetiracetam, Blood |
2505SP |
Levetiracetam, Serum/Plasma |
2506B |
Dextrorphan / Levorphanol Screen, Blood |
2506SP |
Dextrorphan / Levorphanol Screen, Serum/Plasma |
2517B |
Levocetirizine, Blood |
2517SP |
Levocetirizine, Serum/Plasma |
2525B |
Loratadine and Metabolite, Blood |
2525SP |
Loratadine and Metabolite, Serum/Plasma |
2525U |
Loratadine and Metabolite, Urine |
2527B |
Lacosamide, Blood |
2527FL |
Lacosamide, Fluid |
2527SP |
Lacosamide, Serum/Plasma |
2527U |
Lacosamide, Urine |
2531B |
Leflunomide as Metabolite (Therapeutic Drug Monitoring), Blood |
2531SP |
Leflunomide as Metabolite (Therapeutic Drug Monitoring), Serum/Plasma |
2532B |
Leflunomide as Metabolite (Pre-Pregnancy Monitoring), Blood |
2532SP |
Leflunomide as Metabolite (Pre-Pregnancy Monitoring), Serum/Plasma |
2533B |
Loperamide and Metabolite, Blood |
2533SP |
Loperamide and Metabolite, Serum/Plasma |
2540B |
LSD Trace Analysis, Blood |
2540SP |
LSD Trace Analysis, Serum/Plasma |
2540U |
LSD Trace Analysis, Urine |
2541B |
LSD Screen, Blood |
2543B |
Lurasidone, Blood |
2543SP |
Lurasidone, Serum/Plasma |
2581B |
Memantine, Blood |
2581SP |
Memantine, Serum/Plasma |
2584B |
Methylenedioxyamphetamine, Blood |
2584SP |
Methylenedioxyamphetamine, Serum/Plasma |
2584U |
Methylenedioxyamphetamine, Urine |
2585B |
Methylenedioxymethamphetamine and Metabolite, Blood |
2585SP |
Methylenedioxymethamphetamine and Metabolite, Serum/Plasma |
2585U |
Methylenedioxymethamphetamine and Metabolite, Urine |
2665B |
Mercaptopurine and Metabolites, Blood |
2720B |
Metaxalone, Blood |
2720SP |
Metaxalone, Serum/Plasma |
2720U |
Metaxalone, Urine |
2740B |
Metformin, Blood |
2740FL |
Metformin, Fluid |
2740SP |
Metformin, Serum/Plasma |
2740U |
Metformin, Urine |
2810B |
Methamphetamine and Metabolite, Blood |
2810FL |
Methamphetamine and Metabolite, Fluid |
2810SP |
Methamphetamine and Metabolite, Serum/Plasma |
2810U |
Methamphetamine and Metabolite, Urine |
2863SP |
Methazolamide, Serum/Plasma |
2900B |
Methocarbamol, Blood |
2900FL |
Methocarbamol, Fluid |
2900SP |
Methocarbamol, Serum/Plasma |
2915B |
Dextro/Levo Methorphan, Blood |
2915SP |
Dextro/Levo Methorphan, Serum/Plasma |
2915TI |
Dextro/Levo Methorphan, Tissue |
2915U |
Dextro / Levo Methorphan - Total, Urine |
2917U |
Dextromethorphan and Metabolite Ratio - Total, Urine |
2950B |
Methsuximide as Metabolite, Blood |
2950SP |
Methsuximide as Metabolite, Serum/Plasma |
3045B |
Modafinil / Armodafinil, Blood |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3063B |
Mycophenolic Acid and Metabolite, Blood |
3063SP |
Mycophenolic Acid and Metabolite, Serum/Plasma |
3063U |
Mycophenolic Acid and Metabolite, Urine |
3082B |
Molindone, Blood |
3082SP |
Molindone, Serum/Plasma |
3082U |
Molindone, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3099U |
Phthalates Panel, Urine |
3111B |
Naloxone - Free (Unconjugated), Blood |
3111SP |
Naloxone - Free (Unconjugated), Serum/Plasma |
3111U |
Naloxone - Total (Conjugated/Unconjugated), Urine |
3113U |
Naloxone - Total (Conjugated/Unconjugated) Screen, Urine |
3116B |
Naltrexone and Metabolite - Free (Unconjugated), Blood |
3116SP |
Naltrexone and Metabolite - Free (Unconjugated), Serum/Plasma |
3116U |
Naltrexone and Metabolite - Total (Conjugated/Unconjugated), Urine |
3118B |
Nateglinide, Blood |
3118SP |
Nateglinide, Serum/Plasma |
3145B |
Nefazodone, Blood |
3145SP |
Nefazodone, Serum/Plasma |
3145U |
Nefazodone, Urine |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3168B |
Nitazenes Panel, Blood |
3225SP |
Nuedexta®, Serum/Plasma |
3226B |
Olanzapine and Metabolite, Blood |
3226FL |
Olanzapine, Fluid |
3226SP |
Olanzapine and Metabolite, Serum/Plasma |
3226TI |
Olanzapine, Tissue |
3265B |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Blood |
3265SP |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Serum/Plasma |
3325B |
Paraquat, Blood |
3325SP |
Paraquat, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3433SP |
Perampanel, Serum/Plasma |
3440B |
Perphenazine, Blood |
3440SP |
Perphenazine, Serum/Plasma |
3510B |
Phenacetin and Metabolite, Blood |
3510U |
Phenacetin and Metabolite, Urine |
3690B |
Phentermine, Blood |
3690SP |
Phentermine, Serum/Plasma |
3690U |
Phentermine, Urine |
3707B |
Phenylethylmalonamide, Blood |
3707SP |
Phenylethylmalonamide, Serum/Plasma |
3743B |
Phenytoin, Blood |
3743FL |
Phenytoin, Fluid |
3743SP |
Phenytoin, Serum/Plasma |
3743TI |
Phenytoin, Tissue |
3776B |
Pimozide, Blood |
3776SP |
Pimozide, Serum/Plasma |
3779B |
Pioglitazone, Blood |
3779SP |
Pioglitazone, Serum/Plasma |
3901SP |
Primidone, Serum/Plasma |
3970B |
Promethazine, Blood |
3970SP |
Promethazine, Serum/Plasma |
3970TI |
Promethazine, Tissue |
3970U |
Promethazine, Urine |
4025SP |
Ezogabine and Metabolite, Serum/Plasma |
4029B |
Psilocybin as Psilocin (Qualitative), Blood |
4029SP |
Psilocybin as Psilocin (Qualitative), Serum/Plasma |
4029U |
Psilocybin as Psilocin (Qualitative), Urine |
4051B |
Quetiapine, Blood |
4051FL |
Quetiapine, Fluid |
4051SP |
Quetiapine, Serum/Plasma |
4051TI |
Quetiapine, Tissue |
4051U |
Quetiapine, Urine |
4071B |
Quinidine, Blood |
4071SP |
Quinidine, Serum/Plasma |
4075B |
Quinine/Quinidine Differentiation, Blood |
4075SP |
Quinine/Quinidine Differentiation, Serum/Plasma |
4086B |
Ramelteon and Metabolite, Blood |
4086SP |
Ramelteon and Metabolite, Serum/Plasma |
4086U |
Ramelteon and Metabolite, Urine |
4101B |
Repaglinide, Blood |
4101SP |
Repaglinide, Serum/Plasma |
4102B |
Rosiglitazone, Blood |
4102SP |
Rosiglitazone, Serum/Plasma |
4105B |
Risperidone and Metabolite, Blood |
4105FL |
Risperidone and Metabolite, Fluid |
4105SP |
Risperidone and Metabolite, Serum/Plasma |
4105TI |
Risperidone and Metabolite, Tissue |
4105U |
Risperidone and Metabolite, Urine |
4113B |
Paliperidone, Blood |
4113SP |
Paliperidone, Serum/Plasma |
4113U |
Paliperidone, Urine |
4120B |
Ropivacaine, Blood |
4120SP |
Ropivacaine, Serum/Plasma |
4120U |
Ropivacaine, Urine |
4125B |
Rufinamide, Blood |
4125SP |
Rufinamide, Serum/Plasma |
4127B |
Suboxone® - Free, Blood |
4127SP |
Suboxone® - Free, Serum/Plasma |
4127U |
Suboxone® - Total, Urine |
4137B |
Salicylate, Blood |
4137FL |
Salicylate, Fluid |
4137SP |
Salicylate, Serum/Plasma |
4137U |
Salicylate, Urine |
4160B |
Scopolamine, Blood |
4160SP |
Scopolamine, Serum/Plasma |
4160U |
Scopolamine, Urine |
4193B |
Sirolimus, Blood |
4197B |
Sildenafil and Metabolite, Blood |
4197SP |
Sildenafil and Metabolite, Serum/Plasma |
4197U |
Sildenafil and Metabolite, Urine |
4207B |
Canrenone (Spironolactone metabolite), Blood |
4207SP |
Canrenone (Spironolactone metabolite), Serum/Plasma |
4211B |
Stiripentol, Blood |
4211SP |
Stiripentol, Serum/Plasma |
4213U |
Styrene Exposure Profile, Urine |
4215B |
Strychnine, Blood |
4215FL |
Strychnine, Fluid |
4215SP |
Strychnine, Serum/Plasma |
4215TI |
Strychnine, Tissue |
4215U |
Strychnine, Urine |
4236B |
Suvorexant, Blood |
4236SP |
Suvorexant, Serum/Plasma |
4261B |
Hypoglycemic Panel, Blood |
4261SP |
Hypoglycemic Panel, Serum/Plasma |
4275B |
Sumatriptan, Blood |
4275SP |
Sumatriptan, Serum/Plasma |
4275U |
Sumatriptan, Urine |
4297B |
Tadalafil, Blood |
4297SP |
Tadalafil, Serum/Plasma |
4305B |
Tacrine, Blood |
4305SP |
Tacrine, Serum/Plasma |
4306B |
Tacrolimus, Blood |
4311B |
Tamoxifen and Metabolites, Blood |
4311SP |
Tamoxifen and Metabolites, Serum/Plasma |
4366B |
Teriflunomide (Therapeutic Drug Monitoring), Blood |
4366SP |
Teriflunomide (Therapeutic Drug Monitoring), Serum/Plasma |
4367B |
Teriflunomide (Pre-Pregnancy Monitoring), Blood |
4367SP |
Teriflunomide (Pre-Pregnancy Monitoring), Serum/Plasma |
4387B |
Theophylline, Blood |
4387SP |
Theophylline, Serum/Plasma |
4387U |
Theophylline, Urine |
4479B |
Tiagabine, Blood |
4479SP |
Tiagabine, Serum/Plasma |
4487B |
Tizanidine, Blood |
4487SP |
Tizanidine, Serum/Plasma |
4489B |
Tofacitinib, Blood |
4489SP |
Tofacitinib, Serum/Plasma |
4519B |
Topiramate, Blood |
4519FL |
Topiramate, Fluid |
4519SP |
Topiramate, Serum/Plasma |
4519U |
Topiramate, Urine |
4525B |
Torsemide, Blood |
4525SP |
Torsemide, Serum/Plasma |
4535B |
Trazodone and mCPP, Blood |
4535FL |
Trazodone, Fluid |
4535SP |
Trazodone and mCPP, Serum/Plasma |
4535TI |
Trazodone, Tissue |
4535U |
Trazodone and mCPP, Urine |
4660B |
Trifluoperazine, Blood |
4660SP |
Trifluoperazine, Serum/Plasma |
4720B |
Triprolidine, Blood |
4720SP |
Triprolidine, Serum/Plasma |
4757B |
Valproic Acid, Blood |
4757FL |
Valproic Acid, Fluid |
4757SP |
Valproic Acid, Serum/Plasma |
4757TI |
Valproic Acid, Tissue |
4757U |
Valproic Acid, Urine |
4759SP |
Valproic Acid - Unbound and Total, Serum/Plasma |
4761SP |
Valproic Acid, Unbound, Serum/Plasma |
4764B |
Vardenafil and Metabolite, Blood |
4764SP |
Vardenafil and Metabolite, Serum/Plasma |
4774SP |
Vigabatrin, Serum/Plasma |
4778U |
Vinyl Chloride Metabolite, Urine |
4780SP |
Vitamin B3 (Niacin and Metabolites), Serum/Plasma |
4783B |
Voclosporin, Blood |
4791SP |
Vortioxetine, Serum/Plasma |
4815B |
Xylazine, Blood |
4815SP |
Xylazine, Serum/Plasma |
4815TI |
Xylazine, Tissue |
4815U |
Xylazine, Urine |
4821U |
Xylene Exposure Panel, Urine |
4860B |
Ziprasidone, Blood |
4860SP |
Ziprasidone, Serum/Plasma |
4884SP |
Zonisamide, Serum/Plasma |
8088B |
Qsymia®, Blood |
8088SP |
Qsymia®, Serum/Plasma |
8103B |
Environmental Exposure Screen, Blood |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8600B |
Amphetamines Panel, Blood |
8600FL |
Amphetamines Panel, Fluid |
8600ME |
Amphetamines Panel (Qualitative), Meconium |
8600SP |
Amphetamines Panel, Serum/Plasma |
8600TI |
Amphetamines Panel, Tissue |
8600U |
Amphetamines Panel, Urine |
8761B |
Phencyclidine, Blood |
8761FL |
Phencyclidine, Fluid |
8761ME |
Phencyclidine (Qualitative), Meconium |
8761SP |
Phencyclidine, Serum/Plasma |
8761TI |
Phencyclidine, Tissue |
8761U |
Phencyclidine, Urine |
8890OF |
Amphetamines Panel (Qualitative), Oral Fluid (Saliva) |
8896OF |
Phencyclidine and Dextromethorphan (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9142B |
Cyanide Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9182B |
Haloperidol Screen, Blood |
9182SP |
Haloperidol Screen, Serum/Plasma |
9188B |
Ketamine and Metabolite Screen, Blood |
9188SP |
Ketamine and Metabolite Screen, Serum/Plasma |
9188U |
Ketamine and Metabolite Screen, Urine |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9249B |
Pseudoephedrine vs Ephedrine Differentiation Screen, Blood |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9261B |
Scopolamine Screen, Blood |
9261SP |
Scopolamine Screen, Serum/Plasma |
9261U |
Scopolamine Screen, Urine |
9306U |
Anabolic Steroids Screen, Urine |
9318U |
Diuretics Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9404B |
Nicotine and Metabolite Screen, Blood |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |